 Jose Diaz-Miron
Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intestine, Small | 8 | 2017 | 150 | 1.180 |
Why?
| | Surgeons | 5 | 2023 | 260 | 1.150 |
Why?
| | Central Venous Catheters | 1 | 2023 | 48 | 0.840 |
Why?
| | Catheter-Related Infections | 1 | 2023 | 72 | 0.830 |
Why?
| | Intestinal Atresia | 1 | 2023 | 14 | 0.820 |
Why?
| | Catheterization, Central Venous | 1 | 2023 | 103 | 0.780 |
Why?
| | Myofibromatosis | 1 | 2021 | 10 | 0.760 |
Why?
| | Adaptation, Physiological | 6 | 2017 | 513 | 0.680 |
Why?
| | Wounds and Injuries | 2 | 2024 | 711 | 0.610 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 367 | 0.610 |
Why?
| | Neovascularization, Physiologic | 3 | 2015 | 175 | 0.550 |
Why?
| | Short Bowel Syndrome | 5 | 2017 | 26 | 0.500 |
Why?
| | Lung Diseases | 1 | 2022 | 739 | 0.480 |
Why?
| | Coronary Aneurysm | 1 | 2014 | 13 | 0.450 |
Why?
| | Appendectomy | 2 | 2025 | 76 | 0.450 |
Why?
| | Telemedicine | 2 | 2025 | 788 | 0.430 |
Why?
| | Thoracic Injuries | 1 | 2014 | 55 | 0.430 |
Why?
| | Hepatoblastoma | 2 | 2024 | 41 | 0.430 |
Why?
| | Infant, Newborn | 5 | 2024 | 5736 | 0.420 |
Why?
| | Baseball | 1 | 2014 | 58 | 0.420 |
Why?
| | Specialties, Surgical | 2 | 2025 | 73 | 0.420 |
Why?
| | Appendicitis | 2 | 2025 | 125 | 0.410 |
Why?
| | Hemostasis | 1 | 2013 | 79 | 0.410 |
Why?
| | Hematopoiesis | 1 | 2013 | 183 | 0.390 |
Why?
| | Wounds, Nonpenetrating | 1 | 2014 | 271 | 0.360 |
Why?
| | Child | 15 | 2025 | 20785 | 0.320 |
Why?
| | Liver Neoplasms | 2 | 2024 | 640 | 0.310 |
Why?
| | Lung | 1 | 2022 | 3927 | 0.310 |
Why?
| | Intestinal Mucosa | 5 | 2017 | 589 | 0.300 |
Why?
| | Gastrostomy | 2 | 2025 | 110 | 0.270 |
Why?
| | Retrospective Studies | 10 | 2025 | 14461 | 0.250 |
Why?
| | Receptor, IGF Type 1 | 2 | 2017 | 65 | 0.250 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2017 | 25 | 0.250 |
Why?
| | Infant | 9 | 2025 | 8975 | 0.250 |
Why?
| | Retinoblastoma Protein | 2 | 2017 | 54 | 0.250 |
Why?
| | Length of Stay | 3 | 2025 | 1120 | 0.240 |
Why?
| | Chemokine CXCL5 | 2 | 2015 | 11 | 0.230 |
Why?
| | Anastomotic Leak | 1 | 2024 | 38 | 0.230 |
Why?
| | Trisomy 18 Syndrome | 1 | 2024 | 6 | 0.230 |
Why?
| | Esophageal Atresia | 1 | 2024 | 24 | 0.230 |
Why?
| | Competency-Based Education | 1 | 2025 | 71 | 0.220 |
Why?
| | Tracheoesophageal Fistula | 1 | 2024 | 33 | 0.220 |
Why?
| | Humans | 26 | 2025 | 129266 | 0.220 |
Why?
| | Gastric Fistula | 1 | 2024 | 9 | 0.220 |
Why?
| | Perioperative Care | 1 | 2025 | 151 | 0.210 |
Why?
| | Pandemics | 2 | 2022 | 1481 | 0.210 |
Why?
| | Postoperative Care | 1 | 2025 | 241 | 0.210 |
Why?
| | Trauma Centers | 2 | 2024 | 402 | 0.200 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2023 | 21 | 0.200 |
Why?
| | Enoxaparin | 1 | 2023 | 59 | 0.200 |
Why?
| | False Positive Reactions | 1 | 2022 | 114 | 0.190 |
Why?
| | Surgical Wound Infection | 1 | 2025 | 283 | 0.190 |
Why?
| | Fellowships and Scholarships | 1 | 2025 | 273 | 0.190 |
Why?
| | Scalp | 1 | 2021 | 34 | 0.190 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2024 | 272 | 0.180 |
Why?
| | Photography | 1 | 2021 | 93 | 0.180 |
Why?
| | Intestinal Obstruction | 1 | 2021 | 49 | 0.180 |
Why?
| | Operating Rooms | 1 | 2022 | 115 | 0.180 |
Why?
| | Education, Medical, Graduate | 1 | 2025 | 438 | 0.170 |
Why?
| | Healthcare Disparities | 2 | 2024 | 575 | 0.170 |
Why?
| | Pregnancy Outcome | 1 | 2023 | 389 | 0.170 |
Why?
| | Transgender Persons | 1 | 2023 | 172 | 0.170 |
Why?
| | Patient Education as Topic | 1 | 2025 | 737 | 0.170 |
Why?
| | Thrombosis | 1 | 2023 | 343 | 0.160 |
Why?
| | Prospective Studies | 2 | 2022 | 7123 | 0.160 |
Why?
| | Neuroblastoma | 2 | 2011 | 151 | 0.160 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 499 | 0.150 |
Why?
| | Mice, Knockout | 5 | 2017 | 2871 | 0.150 |
Why?
| | Feasibility Studies | 1 | 2022 | 867 | 0.140 |
Why?
| | Clinical Competence | 1 | 2025 | 1016 | 0.140 |
Why?
| | Adolescent | 6 | 2025 | 20313 | 0.140 |
Why?
| | Infant, Premature | 1 | 2021 | 541 | 0.140 |
Why?
| | Patient Satisfaction | 1 | 2021 | 632 | 0.140 |
Why?
| | Curriculum | 1 | 2023 | 910 | 0.140 |
Why?
| | Sensitivity and Specificity | 1 | 2022 | 1839 | 0.140 |
Why?
| | Pediatrics | 1 | 2025 | 1049 | 0.130 |
Why?
| | Male | 13 | 2025 | 63512 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 543 | 0.130 |
Why?
| | Burnout, Professional | 1 | 2022 | 404 | 0.130 |
Why?
| | Parents | 1 | 2025 | 1309 | 0.130 |
Why?
| | Incidence | 1 | 2023 | 2636 | 0.130 |
Why?
| | Mice, Inbred C57BL | 6 | 2015 | 5439 | 0.120 |
Why?
| | Female | 12 | 2025 | 68551 | 0.120 |
Why?
| | Intestinal Absorption | 1 | 2015 | 99 | 0.120 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1708 | 0.110 |
Why?
| | Enterocytes | 1 | 2014 | 15 | 0.110 |
Why?
| | Decision Making | 1 | 2021 | 849 | 0.110 |
Why?
| | Caregivers | 1 | 2021 | 809 | 0.110 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 96 | 0.110 |
Why?
| | Vitamin K Deficiency Bleeding | 1 | 2013 | 3 | 0.110 |
Why?
| | Extracorporeal Circulation | 1 | 2013 | 13 | 0.110 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2013 | 33 | 0.110 |
Why?
| | Dietary Proteins | 1 | 2014 | 129 | 0.110 |
Why?
| | Body Composition | 2 | 2014 | 649 | 0.110 |
Why?
| | Child, Preschool | 5 | 2025 | 10459 | 0.100 |
Why?
| | Intracranial Hemorrhages | 1 | 2013 | 78 | 0.100 |
Why?
| | Diet, High-Fat | 1 | 2014 | 239 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 1 | 2022 | 2515 | 0.100 |
Why?
| | ErbB Receptors | 1 | 2015 | 605 | 0.090 |
Why?
| | Weight Gain | 1 | 2014 | 509 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 64 | 0.090 |
Why?
| | Pregnancy | 1 | 2023 | 6390 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2017 | 328 | 0.080 |
Why?
| | Imidazoles | 1 | 2011 | 234 | 0.080 |
Why?
| | Angiogenesis Inhibitors | 1 | 2011 | 220 | 0.080 |
Why?
| | Neovascularization, Pathologic | 1 | 2011 | 296 | 0.080 |
Why?
| | Patient Readmission | 2 | 2025 | 652 | 0.080 |
Why?
| | Piperazines | 1 | 2011 | 341 | 0.080 |
Why?
| | Animals | 9 | 2017 | 35309 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2011 | 530 | 0.070 |
Why?
| | Bacteria | 1 | 2014 | 813 | 0.070 |
Why?
| | RNA | 1 | 2014 | 880 | 0.070 |
Why?
| | Enteral Nutrition | 2 | 2023 | 188 | 0.070 |
Why?
| | Microbiota | 1 | 2014 | 728 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2009 | 422 | 0.060 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2011 | 758 | 0.060 |
Why?
| | Mice | 7 | 2017 | 16915 | 0.060 |
Why?
| | Postoperative Period | 2 | 2017 | 329 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2537 | 0.060 |
Why?
| | Thoracoscopy | 1 | 2024 | 52 | 0.060 |
Why?
| | Anastomosis, Surgical | 1 | 2024 | 149 | 0.060 |
Why?
| | Disease Models, Animal | 4 | 2014 | 4057 | 0.050 |
Why?
| | Random Allocation | 2 | 2014 | 346 | 0.050 |
Why?
| | Shock | 1 | 2024 | 92 | 0.050 |
Why?
| | Intubation, Gastrointestinal | 1 | 2024 | 76 | 0.050 |
Why?
| | Clinical Protocols | 1 | 2025 | 254 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2009 | 1117 | 0.050 |
Why?
| | Gender Identity | 1 | 2023 | 117 | 0.050 |
Why?
| | Injury Severity Score | 1 | 2024 | 509 | 0.050 |
Why?
| | Disposable Equipment | 1 | 2022 | 19 | 0.050 |
Why?
| | United States | 3 | 2024 | 13826 | 0.050 |
Why?
| | Adenoidectomy | 1 | 2022 | 65 | 0.050 |
Why?
| | Heparin | 1 | 2023 | 253 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2023 | 238 | 0.050 |
Why?
| | Hospital Costs | 1 | 2022 | 114 | 0.050 |
Why?
| | Adhesives | 1 | 2021 | 13 | 0.050 |
Why?
| | Tissue Adhesions | 1 | 2021 | 30 | 0.050 |
Why?
| | Cell Proliferation | 3 | 2015 | 2375 | 0.050 |
Why?
| | Laparoscopy | 1 | 2025 | 449 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1584 | 0.040 |
Why?
| | Intestines | 1 | 2023 | 347 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2014 | 1691 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 431 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1209 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 5384 | 0.040 |
Why?
| | Hospitals, Pediatric | 1 | 2022 | 508 | 0.040 |
Why?
| | Databases, Factual | 1 | 2024 | 1266 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2014 | 2703 | 0.030 |
Why?
| | Apoptosis | 2 | 2015 | 2499 | 0.030 |
Why?
| | Glucose Transporter Type 2 | 1 | 2014 | 11 | 0.030 |
Why?
| | Sodium-Glucose Transporter 1 | 1 | 2014 | 10 | 0.030 |
Why?
| | Fish Oils | 1 | 2014 | 26 | 0.030 |
Why?
| | Tissue and Organ Harvesting | 1 | 2014 | 71 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5050 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1094 | 0.030 |
Why?
| | Microcirculation | 1 | 2014 | 145 | 0.030 |
Why?
| | Tamoxifen | 1 | 2014 | 199 | 0.030 |
Why?
| | Colorado | 1 | 2023 | 4406 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2011 | 3202 | 0.030 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2014 | 138 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 819 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 1204 | 0.020 |
Why?
| | Energy Intake | 1 | 2014 | 461 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 839 | 0.020 |
Why?
| | Risk Factors | 1 | 2024 | 9745 | 0.020 |
Why?
| | Bevacizumab | 1 | 2011 | 129 | 0.020 |
Why?
| | Adult | 2 | 2023 | 35495 | 0.020 |
Why?
| | Mice, Nude | 1 | 2011 | 682 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 274 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2023 | 10202 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 151 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 1063 | 0.020 |
Why?
| | Weight Loss | 1 | 2014 | 732 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 169 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 636 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 184 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 610 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2011 | 812 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 915 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2011 | 509 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 3968 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2146 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2014 | 4887 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2011 | 1344 | 0.010 |
Why?
| | Computational Biology | 1 | 2009 | 595 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1710 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2835 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2014 | 2473 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4077 | 0.010 |
Why?
|
|
Diaz-Miron's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|